Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by KayakerBCon May 15, 2012 3:34pm

215 Views

Post# 19912005

RE: RE: RE: RE: RE: RE: RE: Stocks to Watch

Somebody has to counter your hype with a little dose of reality. You'll get used to it.

You spent a considerable amount of time this year distorting & mischaracterizing my posts, posting personal attacks, even commenting on my wife. My WIFE! All because you can't tolerate any opinions or facts that doesn't conform to your endless pumping & cheerleading. Throw in your McCarthyesque attempts to trash RS's reputation and -- "Houston, we have a problem". Behaviour has consequences. Buckle up.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale